NeuroBo Pharmaceuticals shares are trading higher after a Form4 filing disclosed that Dong-A ST bought 2.54 million shares at an average price of $3.13 per share.
Portfolio Pulse from Benzinga Newsdesk
NeuroBo Pharmaceuticals shares are trading higher following a Form4 filing that revealed Dong-A ST's purchase of 2.54 million shares at an average price of $3.13 per share.
June 25, 2024 | 8:29 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
NeuroBo Pharmaceuticals shares are experiencing a price increase after Dong-A ST purchased 2.54 million shares at $3.13 per share, as disclosed in a Form4 filing.
The purchase of a substantial number of shares by Dong-A ST indicates strong insider confidence in NeuroBo Pharmaceuticals, which is likely to positively influence investor sentiment and drive the stock price higher in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100